Association between statin therapy and amputation-free survival in patients with critical limb ischemia in the CRITISCH registry

Journal of Vascular Surgery

Volumn 66, Issue 5, 2017, Pages 1534-1542

  Stavroulakis, Konstantinos ^a,b   Borowski, Matthias ^c   Torsello, Giovanni ^a,b   Bisdas, Theodosios ^a,b   Adili, Farzin ^d   Balzer, Kai ^d   Billing, Arend ^d   Böckler, Dittmar ^d   Brixner, Daniel ^d   Debus, Sebastian E ^d   Eckstein, Hans Henning ^d   Florek, Hans Joachim ^d   Gkremoutis, Asimakis ^d   Grundmann, Reinhardt ^d   Hupp, Thomas ^d   Keck, Tobias ^d   Gerß, Joachim ^d   Klonek, Wojciech ^d   Lang, Werner ^d   May, Björn ^d   Meyer, Alexander ^d   Mühling, Bernhard ^d   Oberhuber, Alexander ^d   Reinecke, Holger ^d   Reinhold, Christian ^d   Ritter, Ralf Gerhard ^d   Schelzig, Hubert ^d   Schlensack, Christian ^d   Schmitz Rixen, Thomas ^d   Schulte, Karl Ludwig ^d   Spohn, Matthias ^d   Steinbauer, Markus ^d   Storck, Martin ^d   Trede, Matthias ^d   Uhl, Christian ^d   Weis Müller, Barbara ^d   Wenk, Heiner ^d   Zeller, Thomas ^d   Zhorzel, Sven ^d   Zimmermann, Alexander ^d   more..

^a ST FRANZISKUS HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE CORONARY SYNDROME; AGED; AMPUTATION FREE SURVIVAL; BYPASS SURGERY; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONSERVATIVE TREATMENT; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; LIMB AMPUTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVASCULARIZATION; SECONDARY PREVENTION; SURVIVAL; AGE; AMPUTATION; BLOOD; BLOOD VESSEL GRAFT; CLINICAL TRIAL; COMORBIDITY; CRITICAL ILLNESS; DISEASE FREE SURVIVAL; DYSLIPIDEMIAS; ENDOVASCULAR SURGERY; GERMANY; ISCHEMIA; KAPLAN MEIER METHOD; LIMB SALVAGE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; PROTECTION; REGISTER; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AMPUTATION; COMORBIDITY; CRITICAL ILLNESS; DISEASE-FREE SURVIVAL; DYSLIPIDEMIAS; ENDOVASCULAR PROCEDURES; FEMALE; GERMANY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; ISCHEMIA; KAPLAN-MEIER ESTIMATE; LIMB SALVAGE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROTECTIVE FACTORS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME; VASCULAR GRAFTING;

EID: 85028355490     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2017.05.115     Document Type: Conference Paper

References (39)

1. Goldstein, J.L., Brown, M.S., A century of cholesterol and coronaries: from plaques to genes to statins. Cell 161 (2015), 161–172.
2. Endo, A., Kuroda, M., Tanzawa, K., Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett 72 (1976), 323–326.
3. Stone, N.J., Robinson, J.G., Lichtenstein, A.H., Bairey Merz, C.N., Blum, C.B., Eckel, R.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:Pt B (2014), 2889–2934.
4. Wanner, C., Krane, V., März, W., Olschewsk, M., Mann, J.F., Ruf, G., et al. German Diabetes and Dialysis Study Investigators. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 353 (2005), 238–248.
5. Gerhard-Herman, M.D., Gornik, H.L., Barrett, C., Barshes, N.R., Corriere, M.A., Drachman, D.E., et al. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 69 (2017), e71–e126.
6. Tendera, M., Aboyans, V., Bartelink, M.L., Baumgartner, I., Clément, D., Collet, J.P., et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J 32 (2011), 2851–2906.
7. Catapano, A.L., Graham, I., De Backer, G., Wiklund, O., Chapman, M.J., Drexel, H., et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 253 (2016), 281–344.
8. Olin, J.W., Allie, D.E., Belkin, M., Bonow, R.O., Casey, D.E. Jr., Creager, M.A., et al. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease). J Am Coll Cardiol 56 (2010), 2147–2181.
9. Westin, G.G., Armstrong, E.J., Bang, H., Yeo, K.K., Anderson, D., Dawson, D.L., et al. Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia. J Am Coll Cardiol 63 (2014), 682–690.
10. Kumbhani, D.J., Steg, P.G., Cannon, C.P., Eagle, K.A., Smith, S.C. Jr., Goto, S., et al., REACH Registry Investigators. Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry. Eur Heart J 35 (2014), 2864–2872.
11. Schanzer, A., Hevelone, N., Owens, C.D., Beckman, J.A., Belkin, M., Conte, M.S., Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg 47 (2008), 774–781.
12. Sigvant, B., Kragsterman, B., Falkenberg, M., Hasvold, P., Johansson, S., Thuresson, M., et al. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization. J Vasc Surg 64 (2016), 1009–1017.
13. Teraa, M., Conte, M.S., Moll, F.L., Verhaar, M.C., Critical limb ischemia: current trends and future directions. J Am Heart Assoc, 2016, 5.
14. Bisdas, T., Stachmann, A., Weiss, K., Torsello, G., CRITISCH collaborators. German national registry for first-line treatment strategies in patients with critical limb ischemia (CRITISCH registry): study design and current status. Gefaesschirurgie 19 (2014), 135–140.
15. Bisdas, T., Borowski, M., Torsello, G., CRITISCH collaborators. Current practice of first-line treatment strategies in patients with critical limb ischemia. J Vasc Surg 62 (2015), 965–973.
16. Bisdas, T., Borowski, M., Stavroulakis, K., Torsello, G., CRITISCH collaborators. Endovascular therapy versus bypass surgery as first-line treatment strategies for critical limb ischemia: results of the interim analysis of the CRITISCH registry. JACC Cardiovasc Interv 9 (2016), 2557–2565.
17. Fowkes, F.G., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J.O., McDermott, M.M., et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 382 (2013), 1329–1340.
18. Gallino, A., Aboyans, V., Diehm, C., Cosentino, F., Stricker, H., Falk, E., et al. Non-coronary atherosclerosis. Eur Heart J 35 (2014), 1112–1119.
19. Subherwal, S., Patel, M.R., Kober, L., Peterson, E.D., Jones, W.S., Gislason, G.H., et al. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains. Circulation 126 (2012), 1345–1354.
20. Layden, J., Michaels, J., Bermingham, S., Higgins, B., Guideline Development Group. Diagnosis and management of lower limb peripheral arterial disease: summary of NICE guidance. BMJ, 345, 2012, e4947.
21. Vogel, T.R., Dombrovskiy, V.Y., Galiñanes, E.L., Kruse, R.L., Preoperative statins and limb salvage after lower extremity revascularization in the Medicare population. Circ Cardiovasc Interv 6 (2013), 694–700.
22. Dosluoglu, H.H., Lall, P., Harris, L.M., Dryjski, M.L., Long-term limb salvage and survival after endovascular and open revascularization for critical limb ischemia after adoption of endovascular-first approach by vascular surgeons. J Vasc Surg 56 (2012), 361–371.
23. Chung, J., Timaran, D.A., Modrall, J.G., Ahn, C., Timaran, C.H., Kirkwood, M.L., et al. Optimal medical therapy predicts amputation-free survival in chronic critical limb ischemia. J Vasc Surg 58 (2013), 972–980.
24. Scali, S.T., Beck, A.W., Nolan, B.W., Stone, D.H., De Martino, R.R., Chang, C.K., et al. Completion duplex ultrasound predicts early graft thrombosis after crural bypass in patients with critical limb ischemia. J Vasc Surg 54 (2011), 1006–1010.
25. Kim, W., Gandhi, R.T., Peña, C.S., Herrera, R.E., Schernthaner, M.B., Acuña, J.M., et al. The influence of statin therapy on restenosis in patients who underwent nitinol stent implantation for de novo femoropopliteal artery disease: two-year follow-up at a single center. J Vasc Interv Radiol 27 (2016), 1494–1501.
26. Armstrong, E.J., Chen, D.C., Westin, G.G., Singh, S., McCoach, C.E., Bang, H., et al. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc, 3, 2014, e000697.
27. Iida, O., Nakamura, M., Yamauchi, Y., Fukunaga, M., Yokoi, Y., Yokoi, H., et al. 3-Year outcomes of the OLIVE Registry, a prospective multicenter study of patients with critical limb ischemia: a prospective, multi-center, three-year follow-up study on endovascular treatment for infra-inguinal vessel in patients with critical limb ischemia. JACC Cardiovasc Interv 8 (2015), 1493–1502.
28. Suckow, B.D., Kraiss, L.W., Schanzer, A., Stone, D.H., Kalish, J., DeMartino, R.R., et al. Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival. J Vasc Surg 61 (2015), 126–133.
29. Ridker, P.M., MacFadyen, J., Cressman, M., Glynn, R.J., Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention—an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol 55 (2010), 1266–1273.
30. Conte, M.S., Bandyk, D.F., Clowes, A.W., Moneta, G.L., Namini, H., Seely, L., Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 42 (2005), 456–464.
31. Drozda, J.P. Jr., Ferguson, T.B. Jr., Jneid, H., Krumholz, H.M., Nallamothu, B.K., Olin, J.W., et al. 2015 ACC/AHA Focused Update of Secondary Prevention Lipid Performance Measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures. J Am Coll Cardiol 67 (2016), 558–587.
32. Nicholls, S.J., Ballantyne, C.M., Barter, P.J., Chapman, M.J., Erbel, R.M., Libby, P., et al. Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med 365 (2011), 2078–2087.
33. Virani, S.S., Woodard, L.D., Akeroyd, J.M., Ramsey, D.J., Ballantyne, C.M., Petersen, L.A., Is high-intensity statin therapy associated with lower statin adherence compared with low- to moderate-intensity statin therapy? Implications of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guidelines. Clin Cardiol 37 (2014), 653–659.
34. Stroes, E.S., Thompson, P.D., Corsini, A., Vladutiu, G.D., Raal, F.J., Ray, K.K., et al. Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J 36 (2015), 1012–1022.
35. Cholesterol Treatment Trialists' (CTT) Collaboration, Baigent, C., Blackwell, L., Emberson, J., Holland, L.E., Reith, C., Bhala, N., et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376 (2010), 1670–1681.
36. Mammen, A.L., Statin-associated autoimmune myopathy. N Engl J Med 374 (2016), 664–669.
37. Nissen, S.E., Stroes, E., Dent-Acosta, R.E., Rosenson, R.S., Lehman, S.J., Sattar, N., et al. Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the GAUSS-3 randomized clinical trial. JAMA 315 (2016), 1580–1590.
38. Ray, K.K., Kastelein, J.J., Boekholdt, S.M., Nicholls, S.J., Khaw, K.T., Ballantyne, C.M., et al. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J 35 (2014), 960–968.
39. Wei, M.Y., Ito, M.K., Cohen, J.D., Brinton, E.A., Jacobson, T.A., Predictors of statin adherence, switching, and discontinuation in the USAGE survey: understanding the use of statins in America and gaps in patient education. J Clin Lipidol 7 (2013), 472–483.